Pharmacokinetics of valproic acid in volunteers after a single dose study. 1985

M Bialer, and Z Hussein, and I Raz, and O Abramsky, and Y Herishanu, and F Pachys

The pharmacokinetics of valproic acid (VPA) was investigated in six healthy volunteers. This was done by monitoring total and free (unbound) valproic acid levels in the serum, and the amount of one of its metabolites, VPA glucuronide, in the urine as a function of time, after a single dose administration of the parent drug. VPA half-life calculated from the urine data of the metabolite was shorter than the half-life calculated from the blood data. About 15 to 20 per cent of the administered oral dose of VPA was excreted in the urine as VPA glucuronide. The average free fraction of VPA obtained in this study, by using the EMIT technique, ranged from 1.5 to 11.5 per cent with a mean value of 4.9 per cent.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D001798 Blood Proteins Proteins that are present in blood serum, including SERUM ALBUMIN; BLOOD COAGULATION FACTORS; and many other types of proteins. Blood Protein,Plasma Protein,Plasma Proteins,Serum Protein,Serum Proteins,Protein, Blood,Protein, Plasma,Protein, Serum,Proteins, Blood,Proteins, Plasma,Proteins, Serum
D002849 Chromatography, Gas Fractionation of a vaporized sample as a consequence of partition between a mobile gaseous phase and a stationary phase held in a column. Two types are gas-solid chromatography, where the fixed phase is a solid, and gas-liquid, in which the stationary phase is a nonvolatile liquid supported on an inert solid matrix. Chromatography, Gas-Liquid,Gas Chromatography,Chromatographies, Gas,Chromatographies, Gas-Liquid,Chromatography, Gas Liquid,Gas Chromatographies,Gas-Liquid Chromatographies,Gas-Liquid Chromatography
D005965 Glucuronates Derivatives of GLUCURONIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that include the 6-carboxy glucose structure. Glucosiduronates,Glucuronic Acids,Acids, Glucuronic
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014635 Valproic Acid A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS. Dipropyl Acetate,Divalproex,Sodium Valproate,2-Propylpentanoic Acid,Calcium Valproate,Convulsofin,Depakene,Depakine,Depakote,Divalproex Sodium,Ergenyl,Magnesium Valproate,Propylisopropylacetic Acid,Semisodium Valproate,Valproate,Valproate Calcium,Valproate Sodium,Valproic Acid, Sodium Salt (2:1),Vupral,2 Propylpentanoic Acid

Related Publications

M Bialer, and Z Hussein, and I Raz, and O Abramsky, and Y Herishanu, and F Pachys
August 2013, Journal of pharmacokinetics and pharmacodynamics,
M Bialer, and Z Hussein, and I Raz, and O Abramsky, and Y Herishanu, and F Pachys
April 1982, Epilepsia,
M Bialer, and Z Hussein, and I Raz, and O Abramsky, and Y Herishanu, and F Pachys
March 2015, Nutrition research (New York, N.Y.),
M Bialer, and Z Hussein, and I Raz, and O Abramsky, and Y Herishanu, and F Pachys
January 1985, Arzneimittel-Forschung,
M Bialer, and Z Hussein, and I Raz, and O Abramsky, and Y Herishanu, and F Pachys
January 1991, International journal of clinical pharmacology research,
M Bialer, and Z Hussein, and I Raz, and O Abramsky, and Y Herishanu, and F Pachys
July 1984, Antimicrobial agents and chemotherapy,
M Bialer, and Z Hussein, and I Raz, and O Abramsky, and Y Herishanu, and F Pachys
January 1995, European journal of clinical pharmacology,
M Bialer, and Z Hussein, and I Raz, and O Abramsky, and Y Herishanu, and F Pachys
January 1985, Arzneimittel-Forschung,
M Bialer, and Z Hussein, and I Raz, and O Abramsky, and Y Herishanu, and F Pachys
November 1980, Acta pharmacologica et toxicologica,
M Bialer, and Z Hussein, and I Raz, and O Abramsky, and Y Herishanu, and F Pachys
January 2008, Arzneimittel-Forschung,
Copied contents to your clipboard!